Development of a novel neuronal phenotypic in vitro model of familial Alzheimer's disease using the human neuroblastoma-derived immortalized SH-SY5Y cell line
Background Alzheimer's disease (AD) is the most prevalent neurodegenerative disorder and the leading cause of dementia. Despite its undeniable effect on current society, it remains one of the diseases for which clinical trials have the highest failure rate, and therapeutic interventions remain palliative, thus creating an unmet demand to develop translational models that can accelerate pre-clinical drug discovery. Objective We aimed to develop a scalable neuronal phenotypic model using differentiated SH-SY5Y cells with mature neuronal phenotypes. Methods SH-SY5Y were differentiated by exposure to either retinoic acid and phorbol 12-myristate 13-acetate or retinoic acid and GLP-1. Cells differentiated with retinoic acid and GLP-1 were transfected with APP V717I and MAPT P301L mutants. Mutation-induced morphological alterations were measured by immunocytochemistry and neuron activation through intracellular calcium accumulation. Results Transfection induced alterations, including reduced cell densities, neurite lengths, and dendritic arborization, together with increase of amyloid-β (Aβ) aggregation and ROS activity, which are compatible with the neurodegenerative changes observed in AD. A physiological assay based on intracellular calcium imaging revealed hypoexcitability in transfected cultures, suggesting a neurodegenerative process compatible with the later stages of the disease. Treatment of cell cultures with the reference neuroprotective compounds melatonin and resveratrol exerted a significant restorative effect on the morphophysiological variables studied. Conclusions Therefore, we introduce a novel, miniaturized, and automatable in vitro AD model that enables studies on the neurodegenerative mechanisms related to the disease and supports high-throughput screening assays for pre-clinical drug discovery.
Authors
- Jose Manuel Brea (ORCID: https://orcid.org/0000-0002-5523-1979)
- Antón Leandro Martínez (ORCID: https://orcid.org/0000-0002-1595-3459)
- Mateo Barro
- María Isabel Loza
- Magdalena Asensio
- David Moreira
- Neila Cosme
Institutions
- Universidade de Santiago de Compostela (ES)
- Center for Research in Molecular Medicine and Chronic Diseases (ES)
- Instituto de Investigación Sanitaria de Santiago (ES)
Publication Details
- Journal
- Journal of Alzheimer s Disease
- Published
- 2026-11-19
- DOI
- https://doi.org/10.1177/13872877261506370
- Primary Topic
- Alzheimer's disease research and treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00